✦ LIBER ✦

Tyrosine kinase fusion genes in chronic myeloproliferative diseases

✍ Scribed by Cross, N C P; Reiter, A

Book ID: 110055116
Publisher: Nature Publishing Group
Year: 2002
Tongue: English
Weight: 149 KB
Volume: 16
Category: Article
ISSN: 0887-6924
DOI: 10.1038/sj.leu.2402556

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Chronic myeloproliferative disorders: a

Chronic myeloproliferative disorders: a tyrosine kinase tale

✍ De Keersmaecker, K; Cools, J 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 136 KB

Chronic myeloproliferative disorder with

Chronic myeloproliferative disorder with ETV6-PDGFRβ fusion gene

✍ Eswar Tipirneni; Amanpreet Buttar; Doreen Brettler; Patricia Miron; Venu Bathini 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 64 KB

Kinase drug discovery approaches in chro

Kinase drug discovery approaches in chronic myeloproliferative disorders

✍ Kumar, C; Purandare, A V; Lee, F Y; Lorenzi, M V 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 255 KB

ALK fusion genes in children with atypic

ALK fusion genes in children with atypical myeloproliferative leukemia

✍ Röttgers, S; Gombert, M; Teigler-Schlegel, A; Busch, K; Gamerdinger, U; Slany, R 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 432 KB

Transforming mutations in protein—tyrosi

Transforming mutations in protein—tyrosine kinase genes

✍ Jonathan A. Cooper 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 924 KB

Oncogenes are altered forms of normal cellular genes known as proto-oncogenes. Several oncogenes encode enzymes that phosphorylate substrate proteins at tyrosine. In most of these cases the oncogene differs from itsproto-oncogene by multiple mutations that alter the structure of the encodedprotein p

Anagrelide treatment in 52 patients with

Anagrelide treatment in 52 patients with chronic myeloproliferative diseases

✍ E. Penninga; B. A. Jensen; P. B. Hansen; N. T. Clausen; T. Mourits-Andersen; O. 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 84 KB